Skip to main content
Caplight Logo









oDocs Eye Care

oDocs Eye Care

Private
DunedinHealthcare & Life Scienceshttps://www.odocs-tech.com/

Last Round

Grant

Aug 31, 2021

Total Funding Raised

$234,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

oDocs Eye Care is a medical technology company that develops affordable, portable ophthalmic diagnostic tools and teleophthalmology software platforms to improve access to eye care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Telemedicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

ophthalmic imagingsmartphone ophthalmoscopyteleophthalmologymedical deviceportable diagnostic toolsretinal imagingslit lamp adapterfundus cameramHealthdigital healthremote eye screeningpoint of care diagnosticsPOC diagnosticsmedical imaging softwaresocial enterprise

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

oDocs Eye Care Comparables

Compare oDocs Eye Care with similar companies based on industry and business-model similarity.

oDocs Eye Care comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Phelcom Technologies
83%
Epipole Ltd
80%
Remidio
79%

oDocs Eye Care Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 31, 2021
GrantNov 6, 2020
GrantOct 29, 2016

Key People

Founding team and executive leadership

Glenn Linde

CTO

Executive Team

oDocs Eye Care Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 3569% MoM, from 98 to 3.6K.

  • Jan 21, 2026

    Monthly visitors increased 48% MoM.

oDocs Eye Care Filings

Explore SEC and related filing metadata, where available.

oDocs Eye Care filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about oDocs Eye Care's valuation, stock price, and market status.

Is oDocs Eye Care a public or private company?

oDocs Eye Care is a private company.

What is the current stock price of oDocs Eye Care?

oDocs Eye Care is a private company with no public stock price. Caplight tracks oDocs Eye Care's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is oDocs Eye Care worth (valuation)?

Valuation information for oDocs Eye Care is not publicly available.

Can I buy oDocs Eye Care stock?

oDocs Eye Care shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was oDocs Eye Care's last funding round?

oDocs Eye Care's most recent funding round was Grant on August 31, 2021.

Who are the main investors in oDocs Eye Care?

Key investors in oDocs Eye Care include Callaghan Innovation, Health Research Council of New Zealand, Expo City Dubai Foundation.

Will oDocs Eye Care IPO soon?

No public IPO plans have been announced for oDocs Eye Care.

How can I track oDocs Eye Care secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor oDocs Eye Care's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDunedin
Employee Range4
Year Founded2014
Last FundingAug 31, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?